Viewing Study NCT04722900



Ignite Creation Date: 2024-05-06 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 1:54 PM
Study NCT ID: NCT04722900
Status: RECRUITING
Last Update Posted: 2021-09-02
First Post: 2021-01-14

Brief Title: PREG - Offspring Investigation of Children From Mothers With and Without Gestational Diabetes
Sponsor: University Hospital Tuebingen
Organization: University Hospital Tuebingen

Study Overview

Official Title: PREG-Offspring Untersuchung Von Kindern Von Teilnehmerinnen Der Deutschen Studie Gestationsdiabetes PREG-Studie
Status: RECRUITING
Status Verified Date: 2021-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Gestational diabetes is the most common complication during pregrancy With a screening between week 24 and 28 of gestation women with gestational diabetes can be identified and treated Treatment comprises modification of diet and in some cases taking medication This treatment lowers undesirable events like macrosomia or premature birth However unitl gestational diabetes is diagnosed the fetus is exposed to increased intrauterine glucose levels The long-term effects of a well-managed gestational diabetes on the development of the offspring is still not well understood Therefore the PREG - Offspring study investigates several aspects of development in children from healthy and gestational diabetes mothers until adulthood
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None